Ocuphire Pharma Inc. Common Stock is a cutting-edge pharmaceutical company focused on developing and commercializing innovative therapies for various eye disorders. With a deep pipeline of promising drugs and a team of talented scientists, the company aims to make a significant impact on the ophthalmic field.
